Dr Keri Hildick

Keri Hildick, Ph.D. has served as our Chief Strategy Officer since January 2020, having joined in June 2015 and formed our first business development team, which later became our pharma solutions service. Keri has built revenue generating pharma and clinical business units within Perspectum, most recently with dedicated reimbursement codes, broad insurance coverage with premium pricing from commercial and state-based payors. Prior to joining Perspectum, Keri served as a healthcare analyst at Sociable Pharma Ltd, a pharmaceutical market research company (2014 to 2015) and worked as a pharmacology and discovery researcher at GSK (2007 to 2009).

Keri received a Ph.D. in Molecular and Cellular Neuroscience from the University of Bristol (2009-2014) and a BSc. in Pharmacology with Industrial Experience from the University of Edinburgh (2003-2007).